Company intelligence / Profile preview

TODOC

Seoul, Seoul, South Korea

Ownership: Private
Employees: ~5
Development stage: Other

Overview

TODOC's cochlear implant system offers up to 50% cost reduction versus conventional implants via advanced microfabrication. Sullivan (cochlear implant) has completed mechanical, electrical, and limited clinical (cadaver) validation, showing reliability and atraumatic insertion rates; full clinical trials planned. Neuromodulation products (Olius, NerveOn) entering clinical trials for several indications.

Therapeutic areas: NeurologyPsychiatry
Modalities: DeviceNeural interface device (implantable electronics, electrostimulation)
Industry: Implantable Medical Devices

Beyond the preview

Go deeper on TODOC.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TODOC.

Explore the full profile